Short answer
Astrana Health, Inc. (ASTH) filed an 8-K current report with the SEC on June 10, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders approved the amended 2024 Equity Incentive Plan at the June 10, 2026 annual meeting.
Astrana Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Stockholders approved the amended 2024 Equity Incentive Plan at the June 10, 2026 annual meeting
- Share reserve increased by 1,000,000 common shares, creating additional potential equity dilution
- Plan extended through March 24, 2036, supporting longer-term employee and executive retention incentives
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Nine directors elected through 2027 Annual Meeting, with 43,772,595 shares represented and 78.6% voting participation
- Ernst & Young LLP appointment ratified for fiscal year ending December 31, 2026, with 43,722,509 votes supporting
- Executive compensation approved on an advisory basis, with 34,119,199 votes for and 1,209,072 against
- 2024 Plan approved, with 34,679,879 votes for and 701,303 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Astrana Health, Inc. 8-K filings
Get the next ASTH 8-K as it lands
Follow ASTH for push alerts, or ask the research agent what this filing means.